Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2023; 13(8):2616-2631. doi:10.7150/thno.83920 This issue Cite

Review

The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer

Min Liu1,2#, Subo Zhang3#, Heng Zhou4#, Xiaoyun Hu1,2, Jianing Li1,2, Boshi Fu1,2, Minjie Wei1,2,5✉, Huilin Huang3✉, Huizhe Wu1,2✉

1. Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110122, P. R. China.
2. Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation, Liaoning Cancer immune peptide drug Engineering Technology Research Center, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Shenyang, Liaoning 110122, P. R. China.
3. Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, P. R. China.
4. Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P. R. China.
5. Shenyang Kangwei Medical Laboratory Analysis Co. LTD, Shenyang, Liaoning, P. R. China.
#These authors contributed equally to this work: Min Liu; Subo Zhang; Heng Zhou

✉ Corresponding authors: Huizhe Wu, Email: wuhzedu.cn; Huilin Huang, Email: huanghl1org.cn; Minjie Wei, Email: mjweiedu.cn

Citation:
Liu M, Zhang S, Zhou H, Hu X, Li J, Fu B, Wei M, Huang H, Wu H. The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer. Theranostics 2023; 13(8):2616-2631. doi:10.7150/thno.83920. https://www.thno.org/v13p2616.htm
Other styles

File import instruction

Abstract

Graphic abstract

Alternative splicing (AS) is a common and conserved process in eukaryotic gene regulation. It occurs in approximately 95% of multi-exon genes, greatly enriching the complexity and diversity of mRNAs and proteins. Recent studies have found that in addition to coding RNAs, non-coding RNAs (ncRNAs) are also inextricably linked with AS. Multiple different types of ncRNAs are generated by AS of precursor long non-coding (pre-lncRNAs) or precursor messenger RNAs (pre-mRNAs). Furthermore, ncRNAs, as a novel class of regulators, can participate in AS regulation by interacting with the cis-acting elements or trans-acting factors. Several studies have implicated abnormal expression of ncRNAs and ncRNA-related AS events in the initiation, progression, and therapy resistance in various types of cancers. Therefore, owing to their roles in mediating drug resistance, ncRNAs, AS-related factors and AS-related novel antigens may serve as promising therapeutic targets in cancer treatment. In this review, we summarize the interaction between ncRNAs and AS processes, emphasizing their great influences on cancer, especially on chemoresistance, and highlighting their potential values in clinical treatment.

Keywords: Alternative splicing, Non-coding RNA, Cancer, Drug resistance, Chemotherapy, Targeted therapy, Immunotherapy

Citation styles

APA
Liu, M., Zhang, S., Zhou, H., Hu, X., Li, J., Fu, B., Wei, M., Huang, H., Wu, H. (2023). The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer. Theranostics, 13(8), 2616-2631. https://doi.org/10.7150/thno.83920.

ACS
Liu, M.; Zhang, S.; Zhou, H.; Hu, X.; Li, J.; Fu, B.; Wei, M.; Huang, H.; Wu, H. The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer. Theranostics 2023, 13 (8), 2616-2631. DOI: 10.7150/thno.83920.

NLM
Liu M, Zhang S, Zhou H, Hu X, Li J, Fu B, Wei M, Huang H, Wu H. The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer. Theranostics 2023; 13(8):2616-2631. doi:10.7150/thno.83920. https://www.thno.org/v13p2616.htm

CSE
Liu M, Zhang S, Zhou H, Hu X, Li J, Fu B, Wei M, Huang H, Wu H. 2023. The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer. Theranostics. 13(8):2616-2631.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use